Terms: = Cervical cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Staging
733 results:
1. Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer.
Newton C; Graham R; Liberale V; Burnell M; Menon U; Mould T; Olaitan A; Macdonald N; Widschwendter M; Doufekas K; McCormack M; Mitra A; Arora R; Manchanda R
J Obstet Gynaecol; 2024 Dec; 44(1):2344529. PubMed ID: 38708782
[TBL] [Abstract] [Full Text] [Related]
2. Development and validation of a nomogram to predict leptomeningeal metastases in lung adenocarcinoma: cervical lymph node metastasis is an important association factor.
Hua X; Feng W; Ye M; Lai M; Yu X; Sun M; Li J; Ai R; He Y; Cai L; Shi C; Liu X
Cancer Med; 2024 May; 13(9):e7206. PubMed ID: 38686619
[TBL] [Abstract] [Full Text] [Related]
3. SUCCOR morbidity: complications in minimally invasive versus open radical hysterectomy in early cervical cancer.
Vázquez-Vicente D; Boria F; Castellanos T; Gutierrez M; Chacon E; Manzour N; Minguez JA; Martin-Calvo N; Alcazar JL; Chiva L;
Int J Gynecol Cancer; 2024 Feb; 34(2):203-208. PubMed ID: 38669163
[TBL] [Abstract] [Full Text] [Related]
4. [
Adam JA; Poel E; van Eck Smit BLF; Mom CH; Stalpers LJA; Laan JJ; Kidd E; Stoker J; Bipat S
BMC Cancer; 2024 Apr; 24(1):513. PubMed ID: 38654241
[TBL] [Abstract] [Full Text] [Related]
5. MRI Plain Scan: A Tool in the Management of cervical cancer during Pregnancy.
Gao F; Qian T; Sun M; Lu Y; Cheng J; Fu L
Curr Med Imaging; 2024; 20():1-8. PubMed ID: 38389369
[TBL] [Abstract] [Full Text] [Related]
6. The value of the first postoperative diagnostic I-131 scan in patients with papillary thyroid carcinoma.
Ran B; Shang J; Chen Y; Zhou M; Li H; He W; Li Y; Cai Q; Guo B; Gong J; Xu H
J Cancer Res Clin Oncol; 2024 Feb; 150(2):80. PubMed ID: 38319395
[TBL] [Abstract] [Full Text] [Related]
7. Prediction of recurrence-related factors for patients with early-stage cervical cancer following radical hysterectomy and adjuvant radiotherapy.
Ma GF; Lin GL; Wang ST; Huang YY; Xiao CL; Sun J; Shi TY; Xiang LB
BMC Womens Health; 2024 Jan; 24(1):81. PubMed ID: 38297248
[TBL] [Abstract] [Full Text] [Related]
8. The impact of neo/adjuvant treatment choices on prognosis for surgically treated small-cell neuroendocrine carcinoma of the cervix.
Zhao D; Sun S; Yang Z; Wang P; Qiu H
Neoplasma; 2024 Feb; 71(1):70-76. PubMed ID: 38215035
[TBL] [Abstract] [Full Text] [Related]
9. Japan Society of Gynecologic Oncology 2022 guidelines for uterine cervical neoplasm treatment.
Seino M; Nagase S; Tokunaga H; Yamagami W; Kobayashi Y; Tabata T; Kaneuchi M; Hirashima Y; Niikura H; Yoshino K; Takehara K; Baba T; Katabuchi H; Mikami M
J Gynecol Oncol; 2024 Jan; 35(1):e15. PubMed ID: 38037547
[TBL] [Abstract] [Full Text] [Related]
10. MRI-based radiomics features for the non-invasive prediction of FIGO stage in cervical carcinoma: A multi-center study.
Liu Y; Dong TF; Li PJ; Chen LB; Song T
Magn Reson Imaging; 2024 Jul; 110():170-175. PubMed ID: 38035947
[TBL] [Abstract] [Full Text] [Related]
11. Survival outcomes of 2018 FIGO stage IIIC versus stages IIIA and IIIB in cervical cancer: A systematic review with meta-analysis.
Zhang Y; Wang C; Zhao Z; Cheng L; Xu S; Xie P; Xie L; Zhang S
Int J Gynaecol Obstet; 2024 Jun; 165(3):959-968. PubMed ID: 37950594
[TBL] [Abstract] [Full Text] [Related]
12. Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States.
McGarvey N; Gitlin M; Fadli E; Chung KC
J Med Econ; 2023; 26(1):1318-1329. PubMed ID: 37907436
[TBL] [Abstract] [Full Text] [Related]
13. Prevalence of precancerous gynecological lesions and gynecological cancer in patients undergoing vaginal hysterectomy for pelvic organ prolapse.
Suphattanaporn O; Saraluck A; Mononai J; Lekskul N; Chinthakanan O
Ann Med; 2023; 55(2):2273428. PubMed ID: 37883921
[TBL] [Abstract] [Full Text] [Related]
14. The diagnostic yield of preoperative screening for oral cancer in dogs over 15 years, part 1: locoregional screening.
Goldschmidt S; Soltero-Rivera M; Quiroz A; Wong K; Rebhun R; Zwingenberger A; Ren Y; Taylor S; Arzi B
J Am Vet Med Assoc; 2023 Dec; 261(S2):S14-S23. PubMed ID: 37863103
[TBL] [Abstract] [Full Text] [Related]
15. Expanding cervical cancer Screening in Mozambique: Challenges Associated With Diagnosing and Treating cervical cancer.
Batman S; Rangeiro R; Monteiro E; Changule D; Daud S; Ribeiro M; Tsambe E; Bila C; Osman N; Carrilho C; Neves A; Atif H; De Jesus C; Mariano A; Moretti-Marques R; Vieira M; Fontes-Cintra G; Lopes A; Batware JC; Luis E; Grover S; Baker E; Fellman B; Montealegre J; Castle PE; Jeronimo J; Chiao E; Lorenzoni C; Schmeler K; Salcedo MP
JCO Glob Oncol; 2023 Sep; 9():e2300139. PubMed ID: 37824802
[TBL] [Abstract] [Full Text] [Related]
16. A predictive model for patients with local-regionally advanced oropharyngeal squamous cell carcinoma treated after cervical lymph node dissection.
Xie X; Kang M; Qu Z; Gu K
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17241-17251. PubMed ID: 37804427
[TBL] [Abstract] [Full Text] [Related]
17. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H
BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026
[TBL] [Abstract] [Full Text] [Related]
18. Lymph node size detected by magnetic resonance imaging for prediction of lymph node involvement in locally advanced cervical cancer.
Avcı F; Kulhan M; Guler AH; Ates MC; Celik C; Bilgi A; Kulhan NG
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8889-8894. PubMed ID: 37782197
[TBL] [Abstract] [Full Text] [Related]
19. Optimal Size Threshold for MRI-Detected Retropharyngeal Lymph Nodes to Predict Outcomes in Nasopharyngeal Carcinoma: A Two-Center Study.
Zhu Y; Luo C; Zhou S; Li H; Liu L; Kou KI; Lei F; Zhang G; Cao D; Liang Z
AJR Am J Roentgenol; 2024 Jan; 222(1):e2329984. PubMed ID: 37753859
[No Abstract] [Full Text] [Related]
20. Does sentinel node mapping impact morbidity and quality of life in endometrial cancer?
Goncalves BT; Dos Reis R; Ribeiro R; Moretti-Marques R; Schamme FK; Oliveira GS; Tsunoda AT; Alvarenga-Bezerra V; Lopes A; Pastore CBP; Kumagai LY; Faloppa CC; Mantoan H; Badiglian-Filho L; De Brot L; Andrade CEMC; Baiocchi G
Int J Gynecol Cancer; 2023 Oct; 33(10):1548-1556. PubMed ID: 37699707
[TBL] [Abstract] [Full Text] [Related]
[Next]
